AWAK PD Attracts Funding

Singapore-based Awak PD won FDA breakthrough device designation after completing its first-in-human study in October 2018, with no serious adverse events, and has now raised $40M in a financing round to support late-stage clinical studies and commercialization of its portable, wearable, sorbent-based PD device.

Read the full article » | Posted 01-09-2020

Related Articles

• New Measure of Home Dialysis Dropout Posted 01-16-2024
• Check out the NextKidney Neokidney HD Machine Posted 11-15-2023
• New Redsense Clamp Add-on Will Stop the Blood Pump! Posted 10-13-2023
• AWAK Technologies Raised Another $20 million for Shoulder Bag Sized Wearable PD Posted 10-13-2023